BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27239314)

  • 81. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
    Vinik EJ; Hayes RP; Oglesby A; Bastyr E; Barlow P; Ford-Molvik SL; Vinik AI
    Diabetes Technol Ther; 2005 Jun; 7(3):497-508. PubMed ID: 15929681
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Vascular risk factors and diabetic neuropathy.
    Tesfaye S; Chaturvedi N; Eaton SE; Ward JD; Manes C; Ionescu-Tirgoviste C; Witte DR; Fuller JH;
    N Engl J Med; 2005 Jan; 352(4):341-50. PubMed ID: 15673800
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.
    Meijer JW; Smit AJ; Sonderen EV; Groothoff JW; Eisma WH; Links TP
    Diabet Med; 2002 Nov; 19(11):962-5. PubMed ID: 12421436
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
    Coppini DV; Wellmer A; Weng C; Young PJ; Anand P; Sönksen PH
    J Clin Neurosci; 2001 Nov; 8(6):520-4. PubMed ID: 11683597
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Simple screening tests for peripheral neuropathy in the diabetes clinic.
    Perkins BA; Olaleye D; Zinman B; Bril V
    Diabetes Care; 2001 Feb; 24(2):250-6. PubMed ID: 11213874
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
    Stratton IM; Adler AI; Neil HA; Matthews DR; Manley SE; Cull CA; Hadden D; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):405-12. PubMed ID: 10938048
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pressure relieving interventions for preventing and treating diabetic foot ulcers.
    Spencer S
    Cochrane Database Syst Rev; 2000; (3):CD002302. PubMed ID: 10908550
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
    Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
    Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.
    Adler AI; Boyko EJ; Ahroni JH; Stensel V; Forsberg RC; Smith DG
    Diabetes Care; 1997 Jul; 20(7):1162-7. PubMed ID: 9203456
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The association between symptomatic sensory neuropathy and body stature in diabetic patients.
    Sosenko JM; Boulton AJ; Gadia MT; Ward JD; Skyler JS
    Diabetes Res Clin Pract; 1988 Jan; 4(2):95-8. PubMed ID: 3342735
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study.
    Franklin GM; Kahn LB; Baxter J; Marshall JA; Hamman RF
    Am J Epidemiol; 1990 Apr; 131(4):633-43. PubMed ID: 2316495
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration.
    Kumar S; Fernando DJ; Veves A; Knowles EA; Young MJ; Boulton AJ
    Diabetes Res Clin Pract; 1991 Aug; 13(1-2):63-7. PubMed ID: 1773715
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Risk factors for amputation in patients with diabetes mellitus. A case-control study.
    Reiber GE; Pecoraro RE; Koepsell TD
    Ann Intern Med; 1992 Jul; 117(2):97-105. PubMed ID: 1605439
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.
    Paisey RB; Darby T; George AM; Waterson M; Hewson P; Paisey CF; Thomson MP
    BMJ Open Diabetes Res Care; 2016; 4(1):e000163. PubMed ID: 27239314
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Diabetic neuropathy and foot complications.
    Boulton AJ
    Handb Clin Neurol; 2014; 126():97-107. PubMed ID: 25410217
    [TBL] [Abstract][Full Text] [Related]  

  • 97. What you can't feel can hurt you.
    Boulton AJ
    J Vasc Surg; 2010 Sep; 52(3 Suppl):28S-30S. PubMed ID: 20804930
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preventing foot ulcers in patients with diabetes.
    Singh N; Armstrong DG; Lipsky BA
    JAMA; 2005 Jan; 293(2):217-28. PubMed ID: 15644549
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Does this patient with diabetes have large-fiber peripheral neuropathy?
    Kanji JN; Anglin RE; Hunt DL; Panju A
    JAMA; 2010 Apr; 303(15):1526-32. PubMed ID: 20407062
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Preventing and treating foot complications associated with diabetes mellitus.
    Bowling FL; Rashid ST; Boulton AJ
    Nat Rev Endocrinol; 2015 Oct; 11(10):606-16. PubMed ID: 26284447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.